BamSEC and AlphaSense Join Forces
Learn More

Biogen Inc.

NASDAQ: BIIB    
Share price (12/20/24): $146.47    
Market cap (12/20/24): $21.3 billion

Material Contracts Filter

EX-10.1
from 8-K 2 pages Annual Bonus Plan: You Will Be Eligible to Participate in the Biogen Annual Bonus Plan, With a Target Bonus Opportunity of 80% of Your Annual Base Salary. Based Upon Your Promotion Date, Your Target Bonus Amount May Be Pro-Rated. Eligibility Details and Other Terms of the Plan Are Included in the Current Year’s Plan Document, Which Are Available on Biogenconnect. Long-Term Incentive Plan: You Will Be Eligible for an Annual Award in 2025 With a Target Value of $3,750,000. This Award Will Be Granted in Accordance With the Terms of the Lti Plan in Place at the Time of the Grant. Your Employment at Biogen Continues to Be Employment At-Will. This Means That Just as You Are Free to Leave Your Employment at Any Time, With or Without Cause or Notice, Biogen Also Has the Same Right to Terminate Your Employment at Any Time, With or Without Cause or Notice. in Addition to Agreeing to and Signing This Appointment Letter, Please Also Sign the Attached Employee Proprietary Information and Inventions and Non-Compete Agreement, as With This Appointment, You Will Become an Executive Officer of the Company. Finally, Outlined Below Are the Additional Benefits You Are Eligible for as an Evp, Some of Which You Are Already Eligible for as a Vp+ Executive: Additional Executive Benefits Vacation: You Are Entitled to Vacation Days Based on Years of Service Measured From Your Hire Date at Biogen
12/34/56
EX-10.5
from 10-Q 3 pages Non-Employee Director Restricted Stock Unit Award Agreement Granted Under Biogen Inc. 2024 Omnibus Equity Plan
12/34/56
EX-10.4
from 10-Q 3 pages Restricted Stock Unit Award Agreement Granted Under Biogen Inc. 2024 Omnibus Equity Plan
12/34/56
EX-10.3
from 10-Q 5 pages Performance Stock Units Award Agreement Granted Under Biogen Inc. 2024 Omnibus Equity Plan
12/34/56
EX-10.35
from 10-K 9 pages Jva Termination Agreement
12/34/56
EX-10.33
from 10-K 6 pages Material contract
12/34/56
EX-10.32
from 10-K 1 page February 28, 2020 via Electronic Delivery
12/34/56
EX-10.3
from 8-K 26 pages Voting and Support Agreement
12/34/56
EX-10.2
from 8-K 16 pages Voting and Support Agreement
12/34/56
EX-10.1
from 8-K 17 pages Voting and Support Agreement
12/34/56
EX-10.3
from 10-Q 10 pages 1/28/2022 Nicole Murphy NICOLE.MURPHY@BIOGEN.com
12/34/56
EX-10.2
from 10-Q 4 pages Certain Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both Not Material and Is the Type That Biogen Inc. Treats as Private or Confidential. June 9, 2017
12/34/56
EX-10.46
from 10-K 4 pages First Amendment to Amended and Restated Collaboration Agreement
12/34/56
EX-10.45
from 10-K 207 pages Amended and Restated Collaboration Agreement Dated as of October 22, 2017 Between Biogen Ma Inc. and Eisai Co., Ltd
12/34/56
EX-10.20
from 10-K 5 pages Nonqualified Stock Option Award Agreement Granted Under Biogen Inc. 2017 Omnibus Equity Plan
12/34/56
EX-10.1
from 8-K 36 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 17 pages Biogen Inc. 2006 Non-Employee Directors Equity Plan
12/34/56
EX-10.1
from 8-K 4 pages May 2, 2022 Michel Vounatsos C/O Biogen Inc. Re: Continued Employment During CEO Search Dear Michel
12/34/56
EX-10.1
from 10-Q 6 pages Biogen Inc. Performance-Based Management Incentive Plan
12/34/56
EX-10.1
from 10-Q 90 pages Joint Venture Agreement
12/34/56